Literature DB >> 889297

Chronic relapsing experimental allergic encephalomyelitis: an experimental model of multiple sclerosis.

H M Wiśniewski, A B Keith.   

Abstract

Entities:  

Mesh：

Year:  1977        PMID： 889297     DOI： 10.1002/ana.410010207

Source DB:  PubMed          Journal:  Ann Neurol        ISSN： 0364-5134            Impact factor:   10.422


× No keyword cloud information.
  40 in total

1.  Anaphylaxis and mortality induced by treatment of mice with anti-VLA-4 antibody and pertussis toxin.

Authors:  Niannian Ji; Nagarjun Rao; Neal M Guentzel; Bernard P Arulanandam; Thomas G Forsthuber
Journal:  J Immunol       Date:  2011-01-26       Impact factor: 5.422

2.  Evoked potential (EP) alterations in experimental allergic encephalomyelitis (EAE): early delays and latency reductions without plaques.

Authors:  D Gambi; T Fulgente; D Melchionda; M Onofrj
Journal:  Ital J Neurol Sci       Date:  1996-02

3.  Chronic relapsing experimental allergic encephalomyelitis. Studies in vascular permeability changes.

Authors:  K Kristensson; H M Wiśniewski
Journal:  Acta Neuropathol       Date:  1977-08-31       Impact factor: 17.088

4.  Regulation of encephalitogenicity of neuroantigen-primed T cells by nitric oxide: Implications for multiple sclerosis.

Authors:  Susanta Mondal; Saurav Brahmachari; Kalipada Pahan
Journal:  J Clin Cell Immunol       Date:  2012-07-16

5.  Immunocytochemical study of myelin-associated glycoprotein (MAG), basic protein (BP), and glial fibrillary acidic protein (GFAP) in chronic relapsing experimental allergic encephalomyelitis (EAE).

Authors:  H D Webster; H Shii; H Lassmann
Journal:  Acta Neuropathol       Date:  1985       Impact factor: 17.088

6.  Association of inflammatory bowel disease with indicators for childhood antigen and infection exposure.

Authors:  Jochen Hampe; Kerstin Heymann; Michael Krawczak; Stefan Schreiber
Journal:  Int J Colorectal Dis       Date:  2003-04-10       Impact factor: 2.571

7.  Ultrastructural and ultracytochemical studies on the blood-brain barrier in chronic relapsing experimental allergic encephalomyelitis.

Authors:  S Kato; H Nakamura
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

8.  The spleen is required for the suppression of experimental allergic encephalomyelitis by prostaglandin precursors.

Authors:  J Mertin; A Stackpoole
Journal:  Clin Exp Immunol       Date:  1979-06       Impact factor: 4.330

9.  A new model for multiple sclerosis: chronic experimental allergic encephalomyelitis induced by immunization with cerebral endothelial cell membrane.

Authors:  N Tsukada; C S Koh; N Yanagisawa; A Okano; W M Behan; P O Behan
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

10.  Experimental allergic myositis: strain 13 guinea pig immunised with rabbit myosin B fraction.

Authors:  S Matsubara; M Takamori
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.